Legislative and Policy News from February 6, 2019
advertisement
- Spending on Individuals with Type 1 Diabetes and the Role of Rapidly Increasing Insulin Prices
- Trump Administration Proposes to Lower Drug Costs by Targeting Backdoor Rebates and Encouraging Direct Discounts to Patients
- Congress holds first hearings on insulin, high drug prices
- My Wall Street Journal Op-Ed: Don’t Blame Drug Prices on ‘Big Pharma’